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A B S T R A C T   
Adrenal glucocorticoid secretion into the systematic circulation is characterised by a complex rhythm, composed 
of the diurnal variation, formed by changes in pulse amplitude of an underlying ultradian rhythm of short 
duration hormonal pulses. To elucidate the potential neurobiological significance of glucocorticoid pulsatility in 
man, we have conducted a randomised, double-blind, placebo-controlled, three-way crossover clinical trial on 15 
healthy volunteers, investigating the impact of different glucocorticoid rhythms on measures of mood and neural 
activity under resting conditions by recruiting functional neuroimaging, computerised behavioural tests and 
ecological momentary assessments. Endogenous glucocorticoid biosynthesis was pharmacologically suppressed, 
and plasma levels of corticosteroid restored by hydrocortisone replacement in three different regimes, either 
mimicking the normal ultradian and circadian profile of the hormone, or retaining the normal circadian but 
abolishing the ultradian rhythm of the hormone, or by our current best oral replacement regime which results in 
a suboptimal circadian and ultradian rhythm. Our results indicate that changes in the temporal mode of 
glucocorticoid replacement impact (i) the morning levels of self-perceived vigour, fatigue and concentration, (ii) 
the diurnal pattern of mood variation, (iii) the within-network functional connectivity of various large-scale 
resting state networks of the human brain, (iv) the functional connectivity of the default-mode, salience and 
executive control networks with glucocorticoid-sensitive nodes of the corticolimbic system, and (v) the func-
tional relationship between mood variation and underlying neural networks. The findings indicate that the 
pattern of the ultradian glucocorticoid rhythm could affect cognitive psychophysiology under non-stressful 
conditions and opens new pathways for our understanding on the neuropsychological effects of cortisol pulsa-
tility with relevance to the goal of optimising glucocorticoid replacement strategies.   
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1. Introduction 
Adrenal glucocorticoid secretion into the systematic circulation is 
characterised by a complex rhythm, composed of a circadian variation, 
with hormonal levels rising to a diurnal peak during the active part of 
the day followed by a gradual decrease down to the diurnal trough. 
Underlying is an ultradian rhythm formed by short-lasting pulses of 
adrenal glucocorticoid secretion whose amplitude varies in a time-of- 
day-dependent manner (Russell et al., 2015). The characteristics of 
these pulses (duration, amplitude, and frequency) depend on many 
variables including genes, early life experience, age, gender and both 
internal and external stressors (Kalafatakis et al., 2016a). 
In rodents, the diurnal glucocorticoid variation affects the expression 
of many genes (McEwen et al., 2015), regulates dendritic spine forma-
tion (Liston et al., 2013) and impacts emotional behaviour (Ikeda et al., 
2013). Moreover, ultradian rhythmicity differentially regulates 
steroid-sensitive gene expression patterns in the hippocampus (Con-
way-Campbell et al., 2010), prefrontal cortex and pituitary (George 
et al., 2017). It also modulates synaptic plasticity (Sarabdjitsingh et al., 
2014), dynamically defines periods of high and low neuroendocrine 
responsivity to stress (Sarabdjitsingh et al., 2010), influences the elec-
trical activity patterns in the amygdala, modifying the efficacy of 
cognitive processes like fear learning (den Boon et al., 2019), and de-
fines the context in which other neural stimuli with shared molecular 
downstream pathways (like the brain-derived neurotrophic factor) exert 
their effect upon brain cells (Huzard et al., 2020). The molecular basis 
for these rhythm-related biological effects lies on the different binding 
affinities of the two types of corticosteroid receptors with glucocorti-
coids, resulting in a differential activation during the oscillatory activity 
of the hormone, leading consequently to changes of genomic, epi-
genomic and postgenomic cellular events (de Kloet et al., 2018; Kala-
fatakis et al., 2019). 
Does glucocorticoid ultradian rhythmicity affect the human brain 
function as well? The answer to this question is unclear. Until very 
recently, no direct data had been presented on the potential neurobio-
logical significance of glucocorticoid pulsatility in human, as well as its 
clinical implications. Functional neuroimaging studies have observed 
either acute of delayed effects after hydrocortisone administration on 
the neural activation patterns of various corticolimbic regions (such as 
the prefrontal cortex, insula, amygdala or hippocampus) in the context 
of mobilising different cognitive mechanisms, like working memory, 
emotional processing, attentive processing, learning, or even resting 
state conditions (Henckens et al., 2010, 2011, 2012a, 2012b, 2012c; 
Symonds et al., 2012; Veer et al., 2012; Vaisvaser et al., 2013; Vogel 
et al., 2015a, 2015b). Psychological studies have also demonstrated 
temporal differences in subjects’ reward-related decision making 
behaviour following hydrocortisone administration (Riis-Vestergaard 
et al., 2018). Moreover, stress induction studies, modifying endogenous 
systemic cortisol levels, also provide evidence for glucocorticoid 
time-dependent effects on neural activation patterns related to memory 
processing and learning (Vogel et al., 2017; Sep et al., 2019). Finally, 
observational studies suggest that cortisol ultradian dysrhythmicity may 
be causally involved in disorders like chronic insomnia (Vargas et al., 
2018). 
Following the hypothesis that glucocorticoid ultradian rhythmicity 
affects the human brain function, we have conducted a clinical trial on 
healthy volunteers, investigating the impact of different glucocorticoid 
rhythms on neural activity, measured by functional neuroimaging, and 
key markers of mood, cognition and behaviour. Pharmacological 
manipulation was used to suppress subjects’ endogenous glucocorticoid 
rhythm and we infused exogenous cortisol with predetermined rhythms. 
The outcome measures in the clinical trial were classified into two main 
categories: (i) measures of emotional processing, that we presented 
earlier (Kalafatakis et al., 2018), and (ii) measures of mood and neural 
activity under resting conditions, which we are presenting in this paper. 
The outcome measures used in this part of the clinical study (resting 
state functional neuroimaging, ecological momentary assessment) 
represent exploratory analyses which provide clinical hypotheses for the 
future design of mechanistically oriented clinical trials to detail the role 
of glucocorticoid rhythmicity in human brain function. 
2. Materials and methods 
2.1. Introductory remarks 
This was a randomised, double-blind, placebo-controlled, three-way 
crossover study registered with the United Kingdom Clinical Research 
Network (IRAS reference 106181, UKCRN-ID-15236; October 23, 2013). 
Each subject participated into three 5-day long study arms. Block ran-
domisation schedules were generated by staff members not involved in 
data collection; each subject was randomly assigned to one of the six 
possible orders of treatments (Fig. S1). Dispensing and processing of all 
related products was managed by Bristol Royal Infirmary University 
Hospital Pharmacy. In each study arms, subjects were required to take 
the same daily regimen of tablets and remain connected to a subcu-
taneous infusion pump. Anonymized data from all outcome measures 
were stored in the University of Bristol central servers, were cleaned at 
an individual level without knowledge of which session corresponds to 
which subject, and, consequently, further postprocessed and compared 
statistically at a group level, without knowledge of which group corre-
sponds to which mode of hydrocortisone substitution. Sample size was 
estimated based on the results of previous trials using similar neuro-
behavioural measures. 
2.2. Study design 
We recruited right-handed, English-speaking, healthy male in-
dividuals, 18–60 years of age, who did not smoke or smoked less than 6 
cigarettes per day, drank less than 21 units of alcohol per week, and less 
than 4 caffeinated drinks per day. They had not participated in any other 
investigational trial in the last 2 months or were taking any kind of 
medication (prescribed, over the counter, recreational, including topical 
steroids and inhalers). Additionally, we excluded shift workers, or sub-
jects who were dyslectic, claustrophobic or had any other contraindi-
cations for entering the scanner bore. Participants were kept extensively 
informed on the study goals, methods, safety issues and procedures. All 
appropriate measures, to ensure participants’ safety, were planned in 
advance (no such incidences occurred) and any side effects related to the 
treatment schedules recorded. The study also implemented a protocol 
for dealing with incidental findings in brain imaging research (no such 
incidental findings occurred). Finally, based on earlier clinical work in 
similar experimental settings, using neuropharmacological challenge to 
probe psychological mechanisms of mood regulation and emotional 
processing, and functional neuroimaging to measure related neural ac-
tivity (Harmer et al., 2004; Browning et al., 2007; Murphy et al., 2008), 
we performed power calculations that confirmed a sample size of 15 
participants per treatment arm, on whom complete data were available, 
would be required to give our study a 80% power at an alpha level of 5%. 
Further details on the study design and its rationale and limitations can 
be found in the study protocol, published elsewhere (Kalafatakis et al., 
2016b). 
The study was discussed with the Medicines and Healthcare products 
Regulatory Authority (MHRA) who agreed no formal application was 
necessary. The study was conducted according to the principles of the 
Research Governance Framework for Health and Social Care and the 
international conference for harmonisation of good clinical practice 
(ICH GCP, declaration of Helsinki). The Ethics Committee of the Uni-
versity of Bristol approved the study (Ethics approval code: 
2706132525), additionally to the local Research and Development 
(R&D) approval of the University Hospitals Bristol (UHB, National 
Health System Foundation Trust) (reference code: ME/2013/4325), and 
all participants provided written informed consent. 
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2.3. Participants and interventions 
Fifteen volunteers between 20 and 33 years of age were included in 
the study (Table S1) (Kalafatakis et al., 2018). The subjects had no 
history of neuropsychiatric disease as confirmed by clinical assessment 
and were excluded if they had received a diagnosis or had a first-degree 
family history of a psychiatric disorder. Each volunteer passed a detailed 
screening session, part of which was the acquisition of a high-resolution 
anatomic MRI scan (Fig. S1). The cortisol biosynthesis blocking agent 
metyrapone was taken orally in all three arms of the study to render 
them hypoadrenal (per 5-day study arm: 250 mg at lunch and 250 mg 
before going to sleep on the first day, 250 mg at breakfast, 500 mg at 
lunch and 500 mg before going to sleep on the second day, 500 mg at 
breakfast and lunch and 750 mg before going to sleep on the third day, 
750 mg at breakfast and lunch and 1000 mg before going to sleep on the 
fourth day, and finally 750 mg at breakfast on the last day). Glucocor-
ticoid replacement of the same total daily dose (20 mg) was adminis-
tered via three different methods: (i) subcutaneous continuous 
hydrocortisone delivery via a pump (Animas® Vibe™ Insulin Pump), 
with a time-of-day varying rate (2 mg/h between 02:00–08:00, 1 mg/h 
between 08:00–12:00, 0.4 mg/h between 12:00–20:00 and 0.1 mg/h 
between 20:00–02:00), creating a normal circadian but no ultradian 
rhythmicity (SCC group), (ii) subcutaneous hydrocortisone delivery via 
a pump (Crono P®, CANE Applied Medical Technology Ltd, Cambridge, 
UK), delivering pulses of hydrocortisone every 3 h with amplitude 
varying in a time-of-day-dependent manner (4 mg at 03:00, 06:00 and 
09:00, 2.3 mg at 12:00, 15:00, 18:00, and 0.5 mg at 21:00 and 00:00, 
with a rate of 0.1 mg/sec), creating the normal circadian and ultradian 
rhythm (SCP group), and (iii) per os intake of hydrocortisone pills, three 
times daily (10 mg after waking up, and 5 mg at lunch and dinner), 
creating a suboptimal circadian and ultradian cortisol rhythm, formed 
by long-lasting pulses with inconsistent interpulse intervals (PO group). 
2.4. Ecological momentary assessment (EMA) on mood and fatigue 
Throughout each 5-day treatment period (Fig. S2), subjects had to 
carry an android mobile phone running custom EMA software. The de-
vice was programmed to prompt participants to complete three different 
types of surveys: a daily morning report (to be completed by wake up 
until 10 am), a daily evening report (to be completed between 7 pm and 
midnight) and 5–6 surveys randomly spaced over the waking day 
(random prompts). The morning report included 29 statements con-
tained in the Identity Consequences Fatigue Scale (ICFS). The morning 
report also included 9 items about self-perceived reactivity and feeling 
of wellbeing in the form of a visual analogue scale (VASQ) (Fig. S3). 
These 9 items were also answered during the evening report, and during 
the 5–6 random prompt surveys administered each day. Mood was 
assessed at random times, because it varies continuously over the course 
of the day and is not easily conceptualised in an episodic framework. 
2.5. Emotionally-valenced, self-referral word categorisation task (ECAT) 
This task was administered on the last day of each treatment arm 
(Fig. S2). It assesses the speed of responding to twenty positive and 
twenty negative self-referent personality descriptors, which were 
selected to be extremely disagreeable (e.g., boring, untidy, hostile) or 
agreeable (helpful, honest, optimistic). The descriptors were presented 
on the computer screen for 1000 ms, with the inter-stimulus interval 
(time between the disappearance of a previous word and the appearance 
of the next one) being 5000 ms. These words were matched in terms of 
word length and ratings of frequency and meaningfulness. Participants 
were asked to categorise these personality traits as likable or dislikable 
as quickly as possible. Specifically, they were asked to imagine whether 
they would be pleased or upset if they overheard someone else referring 
to them as each descriptor displayed. Participants were encouraged to 
make no response if they didn’t understand the meaning of a particular 
word, and just wait for the next one. Correct classifications in the form of 
%accuracy ([1 – [(N of wrong + N of non-responses)/Total N of tri-
als]] * 100) and reaction times for correct identifications were 
computed for this task. 
2.6. ECAT-related free recall task (EREC) 
This task was administered on the last day of each treatment arm 
(Fig. S2). It is a surprise free recall task to assess the incidental encoding 
of the emotionally-valenced personality descriptors presented during 
the ECAT. About 10 min after the completion of ECAT, volunteers were 
given a piece of paper and a pen and asked to recall and write down as 
many of the personality descriptors from the ECAT (see above) as 
possible within a 2-min time window. The relative recall of positive 
versus negative words gives a measure of emotional biases in memory. 
2.7. Statistical analyses of the behavioural data 
Statistical analysis of the EMA data was performed by STATA® 
release 14. Over the course of the study, 162 ICFS and 1018 VARQ as-
sessments were completed. Their number did not differ between con-
ditions or across study days. As the strength of metyrapone-induced 
adrenal suppression reached its maximum level after the second day per 
study treatment [i.e. the glucocorticoid rhythm was minimally affected 
by any endogenous adrenal activity and based almost solely on the 
distinctively different patterns of exogenous administration, see Kala-
fatakis et al. (2016b) we only retained data from days 3–5 for further 
analysis. Moreover, in relation to the VASQ assessments, it was imper-
ative to have complete datasets from different timepoints across each 
day to be able to model any mood oscillations throughout the day or 
across days. Therefore, we also excluded the few VASQ assessments is-
sued in the morning of day 5, just before the end of the EMA study. 
Eventually, 118 ICFS and 503 VASQ assessments were used for the 
statistical analysis. 
In order to explore the effect of different glucocorticoid rhythms on 
the self-perceived feeling of liveliness after waking up in the morning, 
five independent variables have been created from the ICFS data, ac-
cording to the validated subscales used to score the ICFS (Paddison et al., 
2006); VIGOUR, FATIGUE, DISTRACTION, MOTIVATION and ACTIV-
ITY (Fig. S3). The effect of treatment condition on these five variables 
was estimated using an individual fixed effects model. 
In order to explore the effect of different glucocorticoid rhythms on 
mood variation, principal component analysis was used to reduce the 
nine VASQ items and identify two factors: positive and negative affect 
(see Table S2). The effect of treatment condition on these two factors 
was also evaluated using an individual fixed effects model. Two ap-
proaches were used: (i) the effect of time over the 24-h period on the 
VASQ ratings was assessed for each treatment condition individually 
(circadian variation of mood) (Basabe et al., 2002) and (ii) the effect of 
day on the VASQ ratings was assessed for each treatment condition on 
each day individually for study days 3–4 (across-day evolution of mood). 
Statistical analysis of ECAT and EREC data was performed using 
SPSS® version 23. The influence of the different cortisol rhythms on 
subjects’ response accuracy and reaction time was evaluated with a two- 
way, repeated-measures, mixed-model analysis of variance (ANOVA), 
with the one within-subject factor being treatment group (three levels: 
SCC, SCP, and PO) and the second being emotional valence (two levels: 
positive, negative). Tests for detecting outliers, normality in the distri-
bution of data (Shapiro–Wilk test), and sphericity (Mauchly’s test) have 
been used and taken into consideration for the data analysis. Although 
the assumption of sphericity was not violated in any case, we used 
Greenhouse–Geisser correction regardless. Two-tailed tests were per-
formed for all analyses, and P was set to 0.05. All results shown in the 
corresponding table are mean ± SD. Confidence intervals (CIs) refer to 
± 2 SD. As a measure of the effect size, ω2 was used for the ANOVA. 
Pairwise comparisons with Bonferroni adjustment were performed to 
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investigate any (simple) main effects of treatment across the three study 
groups. 
Two subjects were systematically performing poorly in the verbal- 
dependent behavioural tests (the studentized residuals of the %accu-
racy scores had values lower than − 3). Both participants were non- 
native English speakers (coming from Latin America and Africa 
respectively); the low scores reflect their occasional limited under-
standing of the meaning of the personality descriptors, for most of which 
they’ve chosen to respond (although instructed otherwise) randomly. 
This is a systematic bias which needs to be removed; both subjects were 
therefore excluded from data analysis. 
2.8. Resting state functional neuroimaging study 
The functional neuroimaging study was performed on the last day of 
each treatment arm (Fig. S2). Its technical aspects are described in 
Kalafatakis et al. (2016b). Functional neuroimaging data analyses was 
carried out using FMRIB software library (FSL) 5.0 (Jenkinson et al., 
2012), and involved various preprocessing, postprocessing and valida-
tion steps (Fig. S4). Briefly, these steps consisted of (i) brain intensity 
normalisation, (ii) 3D motion correction (by using FSL linear registra-
tion tool, MCFLIRT), (iii) B0 unwarping, (iv) brain extraction, (v) spatial 
smoothing, (vi) temporal high pass filtering and (vii) co-registration of 
functional images with corresponding high-resolution anatomical im-
ages (by using field maps acquired prior the fMRI experiment) and the 
latter with MNI152 standard space. 
2.9. Strategy for analysing the resting state neuroimaging data 
We used three independent approaches to utilise the resting state 
functional neuroimaging data (Fig. S4). The first of them is totally 
exploratory, implementing independent component analysis (ICA) at 
individual and group-level, data denoising and isolation of group-level 
resting state networks (RSNs) of the human brain, then, for each sub-
ject, estimation of a "version" of each of those group-level RSNs by 
regressing the group-RSNs into each subject’s 4D dataset to give a set of 
time courses and subsequently regressing those time courses into the 
same 4D dataset to get a subject-specific set of RSNs, and finally 
comparing these RSNs across groups of subjects to look for group dif-
ferences. This process is commonly used in the analysis of resting state 
functional neuroimaging data (Zuo et al., 2010; Li et al., 2018). 
For the other two approaches we performed a hypothesis-driven, 
seed-based analysis (rather than an exploratory one across the whole 
brain). We based our hypotheses on three main concepts: (i) brain re-
gions mainly susceptible to glucocorticoid effects (due to the presence of 
glucocorticoid and mineralocorticoid receptors) belong to the cortico-
limbic system of the brain (amygdala, striatum, hippocampus, insula, 
cingulate, orbitofrontal cortex) (Kalafatakis et al., 2016a), which is 
crucial for regulating emotional processing and mood, (ii) particularly in 
the context of positive mood regulation and brain reward circuitry 
dysregulation in mood disorders (Russo and Nestler, 2013), amygdala, 
orbitofrontal cortex and ventral striatum (nucleus accumbens) play an 
important role (Namburi et al., 2016), as clinical (Nitschke et al., 2004) 
and preclinical (Burgdorf and Panksepp, 2006) sources of evidence 
suggest, (iii) there are three widely recognised large-scale RSNs of the 
human brain (default-mode network/ DMN, salience network/ SN, ex-
ecutive control network/ ECN), which either contain or interact with 
parts of the corticolimbic system, and whose neural dynamics are 
affected by glucocorticoid- or stress-related mechanisms (Soares et al., 
2017; Taren et al., 2017; Peters et al., 2016; Thomason et al., 2011), and 
(iv) in our previous report (Kalafatakis et al., 2018), we were able to 
show that various parts of the right-sided corticolimbic system show 
differential neural responses in a glucocorticoid rhythm-dependent 
manner. 
Taking the previously mentioned concepts into consideration, we 
hypothesised (i) that regions of the right-sided corticolimbic system 
might change their functional connectivity with the default-mode 
network, salience network and executive control network depending 
on the underlying glucocorticoid rhythm, and (ii) that positive mood 
variation might relate to different neural network dynamics of the right 
amygdala, right orbitofrontal cortex and right nucleus accumbens in the 
different treatment groups (Fig. S5). 
2.10. Statistical analyses of the neuroimaging data 
Probabilistic ICA was carried out using a subcomponent of FSL 
(MELODIC) (Beckmann and Smith, 2004), in two stages; at individual 
level, independent component maps (IC maps) have been created per 
subject and resting state fMRI session with spatial ICA. The IC maps were 
thresholded using an alternative hypothesis test based on fitting a 
Gaussian/gamma mixture model to the distribution of voxel intensities 
within spatial maps and controlling the local false-discovery rate at p <
0.5. A data denoising system was used based on visual inspection of IC 
maps as described in Kelly et al. (2010). Intensity normalisation across 
volumes of fMRI data was performed, to filter out signals that affect the 
entire brain simultaneously. After removing the noisy components from 
the original 4D dataset, four group ICAs have been performed (one 
including all sessions from all treatment groups, and one per combina-
tion of two treatment groups), each followed by another denoising 
session. 
The three main large-scale RSNs of the human brain (DMN, SN, ECN) 
(Menon, 2011) have been isolated in MNI152 standard space from the 
denoised output of the across-treatments group ICA, and the corre-
sponding regions were subsequently estimated individually for each 
session and each participant in the resting state functional images by 
reversing the spatial transformations that have been applied by 
MELODIC during the corregistration of functional images to the corre-
sponding high-resolution images to MNI152 standard space, and 
timeseries extraction has been applied. These timeseries have been used 
in the correlation analysis with regions of interest (ROIs, see below). 
The analysis for the differences between each of the three combi-
nations of treatment groups was carried out using the FSL dual regres-
sion technique that allows for voxel-wise comparisons of resting-state 
fMRI (Filippini et al., 2009; Veer et al., 2010). This involves using the 
group-ICA spatial maps in a linear model fit against the separate fMRI 
data sets, resulting in time-course matrices describing the temporal 
dynamics for each component and subject, and then using these 
time-course matrices to estimate subject-specific spatial maps. The dual 
regression analysis was performed with variance normalisation. In this 
context, the dual regression reflects differences in both activity and 
spatial spread of the RSNs. The different component maps have been 
tested voxel-wise (paired t-test model per combination of treatment 
groups) for statistically significant differences using FSL Randomize 
nonparametric permutation testing, with up to 10,000 permutations, 
correcting for multiple comparisons voxel-wise. 
Aside the probabilistic approach, we intended to compare the 
strength of correlation between predefined ROIs with DMN, SN and 
ECN, between the three treatment groups. We’ve used the Harvard- 
Oxford subcortical structural atlas in MNI152 standard space to esti-
mate our seeds (see Table S3) (Yan et al., 2009). After seed generation in 
MNI152 standard space, the corresponding seed region was estimated 
individually for each session and each participant in the resting state 
functional images, using the original seed created and reversing the 
spatial transformations that have been applied by MELODIC during the 
corregistration of functional images to the corresponding 
high-resolution images to MNI152 standard space, and timeseries 
extraction has been applied per ROI, subject and treatment arm. Each of 
those timeseries has been tested against the corresponding timeseries of 
the three large-scale RSNs by Spearman’s rank-order correlation anal-
ysis at individual level, and with Fisher z-transformation for group-level 
pairwise comparisons. Level of significance has been set to 0.05. SPSS® 
version 23 and MedCalc® have been used for this purpose. 
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Finally, we wanted to identify certain ROI-dependent, resting state 
networks, whose within-treatment group, between-subject variance in 
the strength of their functional connectivity/ dysconnectivity correlates 
significantly with the corresponding variance in the EMA data referring 
to factor positive affect, acquired a few minutes prior to the MRI scan. 
The ROI-based functional connectivity analysis was performed 
following the methodology proposed by (Di Martino et al., 2008), after 
being validated (Fig. S5). For the correlation analysis, a whole-brain, 
within-group mixed effects model, implemented in FSL (FLAME), was 
used. Nine separate correlation analyses were performed (3 treatment 
groups × 3 seeds). Corrections for multiple comparisons were per-
formed at the cluster level using Gaussian random field theory (mini-
mum z > 2.3, cluster p threshold < 0.05). These group-level analyses 
produced thresholded z score maps highlighting resting state networks, 
functionally associated/ dissociated from each ROI, that have a linear 
positive relationship with the EMA-derived scores reflecting positive 
affect per treatment group. Inherent to the process, correction for mul-
tiple comparisons has been applied. 
3. Results 
3.1. ECAT 
The main effect of treatment might interact with subjects’ perfor-
mance [the F-test just misses significance, F(1.676, 20.113) = 3.622, p 
= 0.052, ω2 = 0.16]. Pairwise comparisons with Bonferroni adjustment 
revealed that, independent of word valence, participants undergoing 
subcutaneous-pulsatile treatment were less accurate at correctly classi-
fying the personality traits compared to both other treatment groups 
(the mean difference with the subcutaneous-continuous treatment group 
is 2.7% with 95% CI − 0.7% to 6.1%, p = 0.141, and the mean differ-
ence with the oral treatment group is 2.9% with 95% CI 0.3–5.5%, p =
0.029). No differences were estimated between treatment groups in their 
reaction times, independent of valence. Across all groups, positively 
valenced personality traits were quicker classified as such compared to 
the negatively valenced ones (p < 0.001) (Fig. 1). 
3.2. EREC 
Analysis of variance elicited a two-way interaction of [valence] ×
[cortisol dynamics] on the number of personality traits falsely recalled 
by the participants (i.e. false alarms; traits that the subjects thought 
they’ve seen during the ECAT session, but were not actually presented) 
[F(1.853, 24.089) = 4.052, p = 0.033, ω2 = 0.17]. Pairwise compari-
sons with Bonferroni adjustment have been performed to investigate any 
significant interactions of the simple main effects of each the two factors 
on the number of these inaccurate recalls; under the subcutaneous- 
pulsatile or the subcutaneous-continuous treatment, when examining 
false alarms, participants mistakenly recall significantly more positive 
than negative personality descriptors (mean difference 0.5 with 95% CI 
Fig. 1. Emotionally-valenced verbal cognitive tests. (ECAT, upper part) Bar-chart presenting each treatment group’s mean reaction time (with the corresponding S.D.) 
for liking positive personality traits and disliking negative ones. Independent of the treatment group and on average, participants tend to respond faster in liking 
personality traits with a positive valence than in disliking personality traits with a negative valence (the mean difference is 128 ms with 95% CI 76–177 ms, 
p < 0.001). (ECAT, lower part) Bar-chart presenting each treatment group’s mean %accuracy score (with the corresponding S.D.) for correctly categorising the 
personality traits as likable and dislikable. The subcutaneous-pulsatile treatment group (SCP) shows a significantly smaller %accuracy compared to the oral treatment 
group (PO) (the mean difference is 2.9% with 95% CI 0.3–5.5%, p = 0.029), and is also smaller (though statistically non-significant) in relation to the subcutaneous- 
continuous treatment group (SCC). (EREC, upper part) Bar-chart presenting each treatment group’s mean number of personality traits correctly recalled by the 
subjects (with the corresponding S.D.). Independent of the treatment group and on average, participants tend to recall more positively valenced personality traits 
than negatively valenced. (EREC, lower part) During the emotional recall task, apart from any accurate recalls, the volunteers were mistakenly recording positive and 
negative personality traits that they thought they’ve encountered during the ECAT session (which took place on average 8.5 min earlier). Participants in the SCP and 
SCC have mistakenly recalled significantly more positive than negative personality descriptors [mean difference 0.5 with 95% CI 0–1, p = 0.047, and 1.3 with 95% CI 
0.4–2.2, p = 0.010, respectively]. ECAT: emotionally-valenced, self-referral word categorisation task, EREC: ECAT-related free recall task, S.D.: standard deviation. 
K. Kalafatakis et al.                                                                                                                                                                                                                            
Psychoneuroendocrinology 124 (2021) 105096
6
0–1, p = 0.047, and mean difference 1.3 with 95% CI 0.4–2.2, p = 0.010 
respectively). No differences were estimated between the treatment 
groups in their capacity to recall personality traits that were actually 
presented (i.e. correct hits), independent of valence. Across all groups, 
subjects could recall more positively valenced personality traits 
compared to negatively valenced ones (p = 0.002) (Fig. 1). 
3.3. EMA 
Ratings of VIGOUR where markedly higher, and those of DISTRAC-
TION significantly lower (i.e. the ability to concentrate was higher), 
during the subcutaneous-continuous treatment compared to the other 
modes of hydrocortisone replacement. On the other hand, ratings of 
FATIGUE were markedly higher during the subcutaneous-pulsatile 
treatment compared to the other modes of hydrocortisone replace-
ment (Fig. 2). 
Individual analysis of each treatment condition over the 24-h cycle 
revealed a circadian decrease of positive mood ratings during the 
subcutaneous-continuous treatment, a circadian increase in positive 
mood ratings during the subcutaneous-pulsatile treatment and no 
change of positive mood ratings during the oral treatment. The opposite 
pattern was found for negative mood rating; during the subcutaneous- 
continuous treatment negative mood ratings exhibited a circadian in-
crease, during the subcutaneous-pulsatile treatment they showed a 
circadian decrease and during the oral treatment no change was found 
(Fig. 2, Table S2). 
We also performed an individual analysis on the oscillatory activity 
of mood for each treatment condition across study days. For the 
subcutaneous-continuous treatment, no individual effect of day was 
found on negative or positive mood ratings. On the contrary, for the 
subcutaneous-pulsatile treatment, negative mood started decreasing on 
study day 3 and continued to do so on study day 4, while positive mood 
ratings increased on study day 4. For the oral treatment, there was some 
indication for the increase of negative mood ratings on study day 3 and a 
restoration on study day 4, while positive mood ratings were increased 
on study day 4 as well (Table S2). 
3.4. Resting state functional neuroimaging data 
The ICA approach revealed various large-scale RSNs which possess a 
differential within-network connectivity depending on the underlying 
mode of hydrocortisone administration (Fig. 3) (Menon, 2011; Chen 
Fig. 2. Self-perceived morning well-being and diurnal mood variation. (Left panel) Bar-charts showing each treatment group’s mean scores (with the corresponding S. 
D.) in the 5 subscales of the Identity-consequence fatigue scale (ICFS). The table underneath presents the p-values of the pairwise comparisons. Ratings of vigour 
where markedly higher in the subcutaneous-continuous treatment group (SCC) compared to the other modes of hydrocortisone replacement. Moreover, ratings of 
distraction were significantly lower (i.e. the ability to concentrate was higher) in the SCC compared to the subcutaneous-pulsatile treatment group (SCP). Similarly, 
with ratings of fatigue. There was no good evidence for an effect of treatment on ICFS ratings related to motivation or activity. To improve clarity, all values have 
been reversed [5-(ICFS score)]. (Right panel) The diurnal mood variation (100: maximally positive mood, − 100: maximally negative mood) was constructed by 
subtracting the negative mood ratings from the corresponding positive mood ratings (as estimated by the self-perceived reactivity and well-being items contained in 
the ecological momentary assessment, see Supplementary Materials and Methods) of days 3 and 4 of each subject and treatment arm. This approach has been 
suggested by prior research (Basabe et al., 2002). In SCC, mood changes are following the circadian glucocorticoid rhythm, possibly with a small delay. The best 
mood of the day occurs just before midday. On the contrary, when exposed to a tightly controlled, pulsatile (ultradian) glucocorticoid rhythm (SCP), the diurnal 
mood variation is dissociated from the hormone’s circadian profile and the best mood of the day occurs in the evening. Finally, when exposed to a non-physiological 
ultradian glucocorticoid rhythm, characterised by infrequent and inconsistent pulses and minimal glucocorticoid availability over the night sleep (PO), the diurnal 
mood variation is less pronounced, compared to the other modes of hydrocortisone bioavailability. CI: confidence intervals, PO: oral treatment group, S.D.: stan-
dard deviation. 
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et al., 2008). Moreover, the seed-based functional connectivity analysis 
indicates that highly glucocorticoid-sensitive, corticolimbic regions (like 
the amygdala, the dorsal and ventral striatum, cingulate, hippocampus, 
orbitofrontal cortex and insula) show a differential connectivity with the 
DMN, SN and ECN depending on the underlying glucocorticoid rhythm 
(Fig. 4). Nevertheless, these hormonal rhythm-dependent changes do 
not alter the characteristic pattern of dynamics between some of the 
ROIs and the three large-scale resting state networks, based on prior 
knowledge (Fig. S6). For instance, the functional connectivity of pos-
terior cingulate with the DMN is stronger in the SCP treatment group 
compared to the other modes of hydrocortisone replacement, although 
in all three treatment groups the BOLD signal of posterior cingulate is, as 
expected, highly correlated with the DMN. Or the functional connec-
tivity of the anterior insula with the SN is weaker in the SCP treatment 
group compared to the other modes of hydrocortisone replacement, 
although in all three treatment groups the BOLD signal of anterior insula 
is, as expected, highly correlated with the SN. Finally, distinct patterns 
of neural network dynamics involving the right amygdala, the nucleus 
accumbens and especially the orbitofrontal cortex correlate with posi-
tive affect variation for each mode of hydrocortisone replacement (Fig. 5 
and Table S4). 
4. Discussion 
In this study, we performed a block and replace protocol (combining 
a glucocorticoid synthesis-blocking agent with three different modes of 
hydrocortisone replacement) together with computerised cognitive 
testing, ecological momentary assessment and resting state functional 
imaging of the brain of healthy individuals to provide evidence on the 
possible significance of glucocorticoid rhythmicity in mood regulation 
and neural dynamics. Our data suggest that glucocorticoid pulsatility 
constitutes a regulatory factor for processes involved in cognitive psy-
chophysiology, including (i) self-perceived domains of well-being, (ii) 
daily mood oscillations, and (iii) resting state neural dynamics, inde-
pendently and in the context of mood regulation. 
The use of VASQ for assessing mood has been long proposed as a 
useful clinical tool, and its reliability and validity verified (Folstein and 
Luria, 1973). This approach has proved more reliable in data collection, 
compared to the traditional pen and paper method (Whybrow et al., 
2006), especially in the context of ecological momentary assessment 
studies, where participants require to record data multiple times daily, 
while being engaged with their non-controlled, often outdoor, routine 
activities (Shiffman et al., 2020). Our version of VASQ has an established 
record of applicability in monitoring positive and negative affect oscil-
lations for investigating behaviour in substance dependence studies 
(Ferguson and Shiffman, 2011; Shiffman et al., 2013; Peacock et al., 
2015). 
Different temporal patterns of hydrocortisone replacement alter the 
morning (post-wakening) levels of self-perceived fatigue, vigour and 
concentration. At this time subjects undergoing the non-pulsatile 
Fig. 3. Functional connectivity within large-scale resting state networks. Aspects of the differential within-network connectivity of large-scale resting state brain 
networks in healthy volunteers exposed to different glucocorticoid ultradian rhythms, as highlighted by independent component analysis and dual regression in FSL 
(corrected for multiple comparisons at voxel level, threshold p < 0.05). The blue/light blue colormaps indicate the resting state networks, while the yellow-red 
colormaps those parts of the network with the altered, treatment-related functional activity. (A) Resting state network involving bilateral medial occipital 
cortices, previously described as a consistent resting state network in man, [see Chen et al. (2008)]. The right-sided lingual gyrus and occipital fusiform gyrus are 
differentially functionally connected with the rest of the network depending on whether subjects are exposed to subcutaneous pulsatile versus non-pulsatile 
glucocorticoid replacement therapy. The coordinate in the z-axis (axial view) refer to MNI152 standard space. (B) Resting state network involving bilateral 
medial occipital cortices, also described as a consistent resting state network in man [see Chen et al. (2008)]. The right-sided lingual gyrus is differentially func-
tionally connected with the rest of the network depending on whether subjects are exposed to subcutaneous continuous versus oral glucocorticoid replacement 
therapy. The coordinate in the x-axis (sagittal view) refer to MNI152 standard space. (C) Resting state network involving the right-sided dorsolateral prefrontal and 
parietal cortices, also described as a consistent resting state network in man [see Chen et al. (2008)]. The angular gyrus, lateral occipital cortex and frontal pole are 
differentially functionally connected with the rest of the network depending on whether subjects are exposed to subcutaneous pulsatile versus oral glucocorticoid 
replacement therapy. The coordinate in the x-axis (sagittal view) refer to MNI152 standard space. FSL: FMRIB software library (Oxford University), PO: oral 
treatment group, SCC: subcutaneous-continuous treatment group, SCP: subcutaneous-pulsatile treatment group. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
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treatment subjectively feel more vigorous and able to concentrate 
compared to pulsatile hormonal replacement whereas subjects on the 
pulsatile treatment feel more fatigued (Fig. 2). On the other hand, 
subjects undergoing non-pulsatile treatment subsequently showed a 
decrease in positive mood and an increase in negative mood throughout 
the rest of the day whereas pulsatile treatment resulted in an increase in 
positive mood and a decrease in negative mood which was maintained 
for the rest of the day (Table S2). These data suggest that in our protocol 
the pulsatile infusions resulted in less liveliness in the morning but 
provided sustained positive mood for longer periods during the day. This 
may well relate to the temporal mode of the hydrocortisone delivery. In 
the non-pulsatile infusion, subjects have a large pulse of cortisol in the 
early morning but have no further pulses during the day. During the 
pulsatile infusion, subjects have a smaller pulse in the early morning but 
continue to experience peaks and troughs of cortisol throughout the day. 
Trying to place these data into the psychophysiological context, it 
helps to briefly summarise current evidence related to mood regulation 
under normal conditions. In healthy subjects, it has been shown that 
mood exhibits a circadian variation (Porto et al., 2006), driven mainly 
by the positive mood. The best mood of the day (greatest difference 
between positive and negative mood) takes place at around midday, 
when positive mood reaches its maximum. After that, it drops steadily 
reaching its minimum at around midnight (Murray et al., 2002). 
Furthermore, behaviour associated with positive mood (laughing, 
socialising, singing) is also characterised by a circadian variation, 
starting from low levels after the morning awaking, and reaching its 
maximum 5–12 h later (Hasler et al., 2008). In addition, features like 
fatigue, confusion and total mood disturbance are high by the morning 
awaking and start decreasing as the day progresses, contrary to vigour 
which starts from lower levels by the morning awaking and increases 
during the day (Monk et al., 1997; Kline et al., 2010). Thus, it seems that 
daily mood variation in subjects undergoing the pulsatile replacement 
(which most closely approximates to the physiological ultradian cortisol 
rhythm) lies closer to current observations of the normal state. This 
notion is further supported by the results of a psycholinguistic study of 
millions of twitter posts recording the use of words that relate to mood 
and thus obtain objective indices of population based circadian mood 
oscillations (Dzogang et al., 2017). In that study, two maxima were 
observed during the weekday: one in the morning and one in the eve-
ning/ night, like the pattern of daily mood oscillations in our pulsatile 
treatment group. Although these are just associations, these all point to 
the importance of combining cutting edge technologies with dynamic 
neurobehavioural tools, to establish the mechanisms underlying the 
relationship between cortisol rhythms and mood oscillations. 
In our current study of brain connectivity we also find that different 
patterns of hydrocortisone replacement are accompanied by changes in 
the within-network functional connectivity of various large scale RSNs, 
and the functional connectivity of the three main RSNs of the human 
brain (DMN, SN, ECN) with corticolimbic regions. Within the network 
responsible for processing visually relevant information, the right 
lingual gyrus showed stronger functionally connectivity with the oc-
cipital cortices bilaterally when subjects receive non-pulsatile gluco-
corticoid replacement compared to pulsatile treatment (either optimal 
or non-optimal) (Fig. 3), while the right-sided orbitofrontal cortex 
showed weaker functional connectivity with the default mode and the 
salience networks when subjects received the pulsatile subcutaneous 
Fig. 4. Functional connectivity of corticolimbic regions with the default mode, salience and executive control networks. (Left part of the figure) Green-purple colour 
heatmap of the correlation coefficient values (Spearman’s rank-order correlation test) between the 10 preselected ROIs and the main large-scale resting state brain 
networks (DMN, SN, ECN) per treatment group (SCC, SCP, PO) and subject. A mean value has been calculated from the resulting correlation coefficients per ROI and 
treatment group, and subsequently these mean values have been compared at treatment group-level after applying Fisher z-transformation (blue-red colourmap, 
significance threshold p < 0.05) (lower right part of the figure). As expected, based on prior knowledge, ROIs (belonging to the corticolimbic system of the brain) show 
higher functional connectivity to SN, and less to DMN (with the prominent exception of PCC) and ECN. Most ROIs are evenly or stronger connected with the three 
brain networks in the glucocorticoid treatment mode lacking the ultradian pulses (SCC) compared to the one comprising the approximation of the normal ultradian 
rhythm (SCP), with the exception of the PCC whose connectivity with DMN is stronger in SCP compared to SCC. Similarly, most ROIs are evenly or stronger 
connected with the three brain networks in the oral glucocorticoid treatment (PO) compared to the one comprising the approximation of the normal ultradian rhythm 
(SCP), with the exceptions of the functional connectivities of PCC with DMN, vACC with SN, and ROFC and RAI with ECN, which are is stronger in SCP compared to 
PO. DMN: default mode network, ECN: executive control network, PCC: posterior cingulate, RAI: right anterior insula, RAmy: right amygdala, RCau: right caudate, 
RHipp: right hippocampus, RNA: right nucleus accumbens, ROFC: right orbitofrontal cortex, ROIs: regions of interest, RPut: right putamen, sACC: middle part of the 
anterior cingulate, SN: salience network, vACC: ventral part of the anterior cingulate PO: oral treatment group, SCC: subcutaneous-continuous treatment group, SCP: 
subcutaneous-pulsatile treatment group. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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treatment compared to the other modes of hydrocortisone replacement 
(Fig. 4). Furthermore, positive mood variations were associated with 
different patterns of amygdala-, nucleus accumbens- and orbitofrontal 
cortex-related brain network dynamics depending on the mode of hy-
drocortisone replacement (Fig. 5). Finally, changes in accuracy of clas-
sification and quality of recollection of emotionally-valenced, self- 
referral descriptors were observed between different treatment groups. 
Mood regulation encompasses the interaction between large-scale 
resting state networks of the brain (responding to internal or external 
cues that modulate the level of arousal, saliency detection and self- 
awareness) with corticolimbic regions (responsible for further inte-
grating emotional cues and stimuli differentially mobilising the stress 
and/or reward system). For instance, it has been shown that negative 
mood is correlated with increased within-network connectivity of the SN 
and decreased connectivity of the DMN (Harrison et al., 2008; Pro-
venzano et al., 2019), while engaging with aesthetically pleasing cues 
increases the functional connectivity of DMN (Vessel et al., 2012). 
Moreover, orbitofrontal cortex is a crucial node for positive mood 
regulation (Nitschke et al., 2004; Rao et al., 2018). In our study, pul-
satile treatment increases the within-network connectivity of DMN and 
reduces that of SN (Fig. 4) compared to the other, suboptimal modes of 
hydrocortisone replacement, a pattern of large-scale neural dynamics 
facilitating positive mood regulation in keeping with these previous 
studies. Furthermore, pulsatile treatment dissociates the functional 
interplay of the right orbitofrontal cortex with DMN and SN (Fig. 4), a 
condition which also correlates with positive mood regulation in our 
study (Fig. 5). Collectively, our findings indicate that changes in the 
ultradian dimension of cortisol dynamics affect cognitive psychophysi-
ology under non-stressful conditions by modulating the neural dynamics 
of resting state networks of the human brain. 
Our findings have major clinical implications for efforts to optimise 
glucocorticoid replacement therapies. Current protocols recommend the 
oral administration of hydrocortisone 2–3 times daily, with the morning 
dose being at least 50% of the total daily amount. We’ve integrated this 
treatment strategy into our study, as one of the three different modes of 
cortisol replacement. This strategy creates a form of suboptimal hor-
monal pulsatility, with the circadian peak occurring after waking up in 
the morning, with a much smaller number of daily pulses, and with an 
inconsistent, usually much-longer-than-normal, duration of inter-pulse 
intervals. In addition to our previously published report on emotional 
processing (Kalafatakis et al., 2018), the data we present here further 
indicate that this commonly used replacement protocol results in sig-
nificant neuropsychological differences to a more physiological regime. 
Over the last decade, an alternative approach for cortisol replace-
ment has been proposed, involving the continuous, non-pulsatile pump- 
mediated subcutaneous infusion of hydrocortisone, mimicking the 
circadian but ignoring the ultradian pattern of plasma cortisol. We felt it 
was important to integrate this strategy into our study as there is evi-
dence it might improve markers of fatigue, vitality and physical func-
tion, especially after a period of many weeks to months (Oksnes et al., 
Fig. 5. Associations between positive mood oscillations and amygdala-, nucleus accumbens- and orbitofrontal cortex-related brain network dynamics. Within- 
treatment-group correlation analysis between three seed-related resting state networks and the scores of a positive affect scale developed based on volunteers’ 
ratings in relevant questions (via ecological momentary assessment, see Supplementary Materials and Methods). For each treatment group, positive affect variation 
has been associated with a distinct pattern of interactions between the seed regions (right amygdala/ AMY, right lateral orbitofrontal cortex/ OFC and right nucleus 
accumbens/ NA) and other areas of the brain. In the subcutaneous-continuous treatment group (SCC), the across-individuals variation in positive affect can be 
explained by (i) the degree of attenuation in the functional connectivity between NA and parts of the right paracingulate cortex, superior frontal gyri and the right 
frontal pole (dotted red line), and (ii) the degree of increase in the functional connectivity (continuous thick green line) between OFC and parts of the left-sided 
orbitofrontal cortex and temporal pole. In the oral treatment group (PO), the across-individuals variation in positive affect can be explained by the degree of 
attenuation in the functional connectivity between the OFC and same-sided regions responsible for the processing of somatosensory input (lingual gyrus, cuneal 
cortex and areas around the calcarine sulcus) and the left precentral gyrus (dotted red lines). Finally, in the subcutaneous-pulsatile treatment group (SCP), the across- 
individuals variation in positive affect can be explained by the degree of attenuation in the functional connectivity (i) between AMY and parts of the right-sided 
salience network, (ii) between NA and left-sided frontal pole and inferior frontal gyrus, and (iii) between OFC and extensive brain regions, from both hemi-
spheres, involving core nodes of the salience, default-mode and executive control networks, as well as other regions responsible for visual processing (dotted red 
lines). L.: left, R.: right. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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2014; Gagliardi et al., 2014; Nella et al., 2016; Mallappa et al., 2018). 
Although our study was able to replicate some of these findings over a 
much shorter treatment period, in our healthy subjects, we were also 
able to show marked differences between the pulsatile and non-pulsatile 
modes of replacement on the mood response of our subjects over the 
day. That type of knowledge will be crucial as we develop a personalised 
medicine approach to glucocorticoid hormone replacement. 
Due to the inter-individual differences in ultradian patterns of 
cortisol secretion it would not have been feasible to include a non- 
treated ‘control’ group in this study. We would simply not have 
known the timing of the endogenous rhythm in any subject in relation to 
our outcome measures; the computerised psychological tests or the fMRI 
scanning protocol would have been performed at random times during 
the subjects’ ultradian cycles, preventing the ability to place the results 
into a biological context and interpret them in relation to physiology. In 
the future, using smart devices able to perform continuous, minimally 
invasive estimations of plasma cortisol dynamics or mathematical 
models able to predict daily plasma cortisol dynamics from only a few 
blood sampling measurements, it might be possible to reliably include 
such a “control” group into studies of similar design. 
A limitation of this study was the relatively short duration over 
which we could ethically maintain our volunteers on the block and 
replace treatment regimens. A previously published trial however has 
already validated and standardised our block and replace protocol and 
showed biochemical evidence of successful recapitulation of physio-
logical levels of plasma cortisol by all replacement strategies (Kalafa-
takis et al., 2016b). Future studies in patients with adrenocortical 
insufficiency are now needed with much longer duration in each treat-
ment group to better characterise the neuropsychological effects of our 
novel, pump-mediated, pulsatile subcutaneous replacement therapy. 
This should hopefully provide the evidence needed to improve gluco-
corticoid treatment regimens, help reduce the morbidity of current 
replacement therapy and reduce the long-term neuropsychiatric prob-
lems of patients with adrenocortical insufficiency. 
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Henckens, M.J., van Wingen, G.A., Joëls, M., Fernández, G., 2011. Time-dependent 
corticosteroid modulation of prefrontal working memory processing. Proc. Natl. 
Acad. Sci. USA 108, 5801–5806. https://doi.org/10.1073/pnas.1019128108. 
Henckens, M.J., Pu, Z., Hermans, E.J., van Wingen, G.A., Joëls, M., Fernández, G., 2012a. 
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